Heparin Market Report 2026

Heparin Market Overview

• Heparin market size has reached to $10.23 billion in 2025 • Expected to grow to $14.67 billion in 2030 at a compound annual growth rate (CAGR) of 7.5% • Growth Driver: The Surge In Surgical Procedures Fuels Growth In The Heparin Market • Market Trend: Product Advancements Driving Growth In The Heparin Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Heparin Market?

Heparin refers to an anticoagulant type substance that slows the development of blood clots. Heparin is produced by the liver, lungs, and other human tissues, but it can also be produced in a lab. In order to prevent or dissolve blood clots, heparin may be injected into muscle or blood. Heparin is widely used in hospitals to prevent excessive coagulation during cardiac surgery, extracorporeal circulation, or dialysis. The main types of heparin include unfractionated heparin, low molecular weight heparin (LMWH), and ultra-low molecular weight heparin (ULMWH). The unfractionated heparin (UFH) market refers to a class of fast-acting anticoagulant medication that prevents clot formation by combining with antithrombin. Unfractionated heparin binds to antithrombin and improves its ability to inhibit two of the body's most powerful clotting factors, factor Xa and factor IIa, in minutes. They are sourced from bovine or porcine and administered intravenous or subconscious. they are used in the treatment of venous thromboembolism, atrial fibrillation, renal impairment, coronary artery disease, and others. They are distributed through hospital pharmacies, drug stores or retail pharmacies, and online pharmacies.

What Is The Heparin Market Growth Forecast?

The heparin market size is expected to see strong growth in the next few years. It will grow to $14.67 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to rising prevalence of venous thromboembolism, aging population with chronic disorders, expanding use of LMWH in outpatient care, growth of specialty pharmacies, increasing focus on preventive anticoagulation. Major trends in the forecast period include rising adoption of low molecular weight heparin, growing hospital-based anticoagulation protocols, increased demand for dialysis and cardiac care applications, shift toward pre-filled and ready-to-use injectables, expansion of online and retail pharmacy distribution.

Global Heparin Market Segmentation

1) By Product: Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra-Low Molecular Weight Heparin (ULMWH) 2) By Source: Bovine, Porcine 3) By Route of Administration: Intravenous, Subcutaneous 4) By Application: Venous Thromboembolism, Atrial Fibrillation, Renal Impairment, Coronary Artery Disease, Other Applications 5) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Pharmacies Subsegments: 1) By Unfractionated Heparin: Injectable Formulations, Intravenous (IV) Solutions 2) By Low Molecular Weight Heparin (LMWH): Enoxaparin, Dalteparin, Tinzaparin 3) By Ultra-Low Molecular Weight Heparin (ULMWH): Specific Formulations For Specialized Therapies

What Is The Driver Of The Heparin Market?

The rising surgical procedure is expected to boost the growth of the heparin market going forward. A surgical procedure refers to a medical intervention or treatment method that involves making incisions or using minimally invasive techniques to access and manipulate the body's tissues or organs. The growing number of surgical procedures necessitates the use of heparin, an anticoagulant, to prevent blood clots during and after surgery, thereby fueling the demand for heparin and driving the growth of the heparin market. For instance, in February 2024, according to the American Academy of Facial Plastic and Reconstructive Surgery, a US-based non-profit organization, approximately 83% of all medical procedures performed in 2023 were minimally invasive, with standard surgical procedures accounting for the remaining 17%. Moreover, in 2023, according to the American Society of Plastic Surgeons, a US-based specialty organization, the total number of cosmetic minimally invasive procedures increased from 23.7 million in 2022 to 25.4 million in 2023. Therefore, the rising surgical procedures is driving the growth of the heparin industry.

Key Players In The Global Heparin Market

Major companies operating in the heparin market are Baxter International Inc., B. Braun Medical Inc., Dr. Reddy's Laboratories Ltd., Fresenius SE & Co. KGaA, Leo Pharma A/S, Aspen Pharmacare plc, Bioiberica SA, Biomedical Foscama Group, Biovet SA, Changzhou Qianhong Bio-pharma Co. Ltd., CSPC NBP Pharmaceutical Co. Ltd., Intas Pharmaceuticals Ltd., Nanjing King-friend Biochemical Pharmaceutical Co. Ltd., Opocrin Pharmaceuticals Ltd., Pfizer Inc., Pharma Action Ltd., Rovi Pharma Industrial Services Ltd., Sagent Pharmaceuticals Inc., Sanofi S. A., Shenzhen Hepalink Pharmaceutical Co. Ltd., Sichuan Deebio Pharmaceutical Co. Ltd., Teva Pharmaceuticals Industries Ltd., VAV Life Sciences Inc., Viatris Inc., Wanbang Biopharmaceuticals Co. Ltd., Wockhardt Ltd., Xinbai Pharmaceuticals Co. Ltd., Yino Pharma Co. Ltd.

Global Heparin Market Trends and Insights

Major companies operating in the heparin market are focused on developing innovative solutions to enhance drug efficacy, improve safety profiles, and reduce side effects, while also exploring advanced delivery methods and biosimilar development to meet growing global demand. Heparin Sodium Chloride Injection is a sterile solution that combines heparin, an anticoagulant (blood thinner), with sodium chloride, which is commonly used to maintain osmotic balance and stability in the solution. For instance, in February 2024, B. Braun Medical Inc., a US-based medical company, launched Heparin Sodium 2,000 Units in 0.9% Sodium Chloride Injection, available in a 1,000 mL EXCEL IV container at a concentration of 2 units/mL. This product is the fifth addition to B. Braun's Heparin portfolio and is designed to meet the diverse needs of healthcare facilities for this critical anticoagulant medication.

What Are Latest Mergers And Acquisitions In The Heparin Market?

In May 2023, Bioiberica, a Spain-based pharmaceutical ingredients and API company that manufactures heparin, partnered with Vall Companys to establish Biovall Heparin Science, a joint business venture backed by a $28.81 million (€25 million) investment. Through this collaboration, the companies aim to advance sustainable heparin production by implementing a circular economy model that leverages porcine intestinal mucosa co-products to generate crude heparin while ensuring full traceability, quality, and safety across the supply chain. Vall Companys is a Spain-based agri-food group and leading pork producer.

Regional Insights

North America was the largest region in the heparin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Heparin Market?

The heparin market consists of sales of enoxaparin, dalteparin, and nadroparin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Heparin Market Report 2026?

The heparin market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the heparin industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.